SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-24-022658
Filing Date
2024-08-20
Accepted
2024-08-20 17:39:04
Documents
1
Period of Report
2024-08-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1406
  Complete submission text file 0001127602-24-022658.txt   3175
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
Charhon Jean-Jacques (Reporting) CIK: 0001725564 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 241226483